FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
EP1489184A1
(en)
*
|
1995-06-07 |
2004-12-22 |
Inex Pharmaceutical Corp. |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
FR2739292B1
(fr)
*
|
1995-09-28 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
|
GB2324534B
(en)
*
|
1996-01-06 |
2000-05-10 |
Danbiosyst Uk |
Composition for delivery of nucleic acid to a cell
|
ATE220559T1
(de)
*
|
1996-10-23 |
2002-08-15 |
Sueddeutsche Kalkstickstoff |
Verfahren zur herstellung von biologisch aktiven polymernanopartikel-nucleinsäure-konjugaten
|
ES2392246T3
(es)
*
|
1996-11-12 |
2012-12-07 |
The Regents Of The University Of California |
Preparación de formulaciones estables de complejos de lípido-ácido nucleico para el suministro eficaz in vivo
|
US6884430B1
(en)
|
1997-02-10 |
2005-04-26 |
Aventis Pharma S.A. |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
|
ATE466948T1
(de)
|
1997-03-11 |
2010-05-15 |
Univ Minnesota |
Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle
|
US5912225A
(en)
|
1997-04-14 |
1999-06-15 |
Johns Hopkins Univ. School Of Medicine |
Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
|
US6524613B1
(en)
|
1997-04-30 |
2003-02-25 |
Regents Of The University Of Minnesota |
Hepatocellular chimeraplasty
|
DE19726186A1
(de)
*
|
1997-06-20 |
1998-12-24 |
Boehringer Ingelheim Int |
Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen
|
US20020022034A1
(en)
*
|
1997-09-15 |
2002-02-21 |
Julianna Lisziewicz |
Therapeutic DNA vaccination
|
ES2279580T3
(es)
*
|
1997-09-15 |
2007-08-16 |
Genetic Immunity, Llc |
Composiciones para administrar genes a celulas de la piel que presentan antigenos.
|
DE19743135A1
(de)
*
|
1997-09-30 |
1999-04-01 |
Hoechst Marion Roussel De Gmbh |
Biologisch verträgliche niedermolekular Polyethylenimine
|
CA2335460A1
(en)
*
|
1998-06-18 |
1999-12-23 |
Johns Hopkins University School Of Medicine |
Polymers for delivery of nucleic acids
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
WO2000025748A1
(fr)
*
|
1998-11-02 |
2000-05-11 |
Terumo Kabushiki Kaisha |
Liposomes
|
US7160682B2
(en)
*
|
1998-11-13 |
2007-01-09 |
Regents Of The University Of Minnesota |
Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
|
IL145592A0
(en)
*
|
1999-04-02 |
2002-06-30 |
Res Dev Foundation |
Polyethyleneimine: dna formulations for aerosol delivery
|
US6770740B1
(en)
|
1999-07-13 |
2004-08-03 |
The Regents Of The University Of Michigan |
Crosslinked DNA condensate compositions and gene delivery methods
|
FR2797402B1
(fr)
|
1999-07-15 |
2004-03-12 |
Biomerieux Stelhys |
Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
|
DE19960206A1
(de)
*
|
1999-12-14 |
2001-07-19 |
Frank Czubayko |
Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung
|
AU782912B2
(en)
|
1999-12-28 |
2005-09-08 |
Association Francaise Contre Les Myopathies |
Use of lithium (Li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
|
JP2003519199A
(ja)
*
|
1999-12-30 |
2003-06-17 |
ノバルティス アクチエンゲゼルシャフト |
遺伝子治療のための新規なコロイド合成ベクター
|
FR2805271B1
(fr)
*
|
2000-02-18 |
2002-04-26 |
Aventis Pharma Sa |
Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
|
FR2813605B1
(fr)
*
|
2000-09-05 |
2002-10-18 |
Aventis Pharma Sa |
Composes acidosensibles, leur preparation et utilisations
|
ATE312088T1
(de)
*
|
2000-09-05 |
2005-12-15 |
Centelion |
Säureempfindliche verbindungen, deren herstellung und verwendungen
|
FR2814370B1
(fr)
*
|
2000-09-22 |
2004-08-20 |
Centre Nat Rech Scient |
Utilisation d'un complexe acide nucleique/pei pour le ciblage de cellules souches du cerveau
|
DE10145134A1
(de)
*
|
2000-10-09 |
2002-05-16 |
Bayer Ag |
Komplexe zur Einführung von Nukleinsäuren in Zellen
|
CN1479632A
(zh)
*
|
2000-10-09 |
2004-03-03 |
拜尔公司 |
用于将核酸导入细胞的复合物
|
US20020091242A1
(en)
|
2000-10-11 |
2002-07-11 |
Michel Bessodes |
Acid-sensitive compounds, their preparation and uses
|
EP1355628A2
(en)
*
|
2001-02-01 |
2003-10-29 |
Board of Regents, The University of Texas System |
Stabilised polymeric aerosols for pulmonary gene delivery
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
US20040234586A1
(en)
*
|
2001-06-11 |
2004-11-25 |
Sylvain Meloche |
Compositions and methods for enhancing nucleic acid transfer into cells
|
AU2002339224B2
(en)
|
2001-09-14 |
2008-10-09 |
Kuros Us Llc |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
WO2003040399A2
(en)
*
|
2001-11-02 |
2003-05-15 |
Intradigm Corporation |
Therapeutic methods for nucleic acid delivery vehicles
|
EP1479985B1
(en)
|
2002-01-17 |
2017-06-14 |
Alfa Laval Corporate AB |
Submerged evaporator comprising a plate heat exchanger and a cylindric casing where the plate heat exchanger is arranged
|
WO2003089618A2
(en)
*
|
2002-04-22 |
2003-10-30 |
Regents Of The University Of Minnesota |
Transposon system and methods of use
|
ES2328031T3
(es)
|
2002-05-24 |
2009-11-06 |
F. Hoffmann-La Roche Ag |
Composiciones para distribuir acidos nucleicos a celulas.
|
AU2003245160B2
(en)
|
2002-06-28 |
2009-09-24 |
Arbutus Biopharma Corporation |
Method and apparatus for producing liposomes
|
US20050196382A1
(en)
*
|
2002-09-13 |
2005-09-08 |
Replicor, Inc. |
Antiviral oligonucleotides targeting viral families
|
CN1694959B
(zh)
*
|
2002-09-13 |
2013-09-18 |
雷普利瑟公司 |
非序列互补的抗病毒寡核苷酸
|
EP1413874A1
(en)
|
2002-10-16 |
2004-04-28 |
Streck Laboratories, Inc. |
Method and device for collecting and preserving cells for analysis
|
WO2004083450A2
(en)
*
|
2003-03-21 |
2004-09-30 |
The General Hospital Corporation D/B/A Massachusetts General Hospital |
Hyperbranched dendron and methods of synthesis and use thereof
|
EP2567693B1
(en)
|
2003-07-16 |
2015-10-21 |
Protiva Biotherapeutics Inc. |
Lipid encapsulated interfering RNA
|
AU2004272646B2
(en)
|
2003-09-15 |
2011-11-24 |
Arbutus Biopharma Corporation |
Polyethyleneglycol-modified lipid compounds and uses thereof
|
JP2007527240A
(ja)
*
|
2004-03-01 |
2007-09-27 |
マサチューセッツ インスティテュート オブ テクノロジー |
アレルギー性鼻炎および喘息のためのRNAiベースの治療
|
EP1730286A4
(en)
*
|
2004-03-04 |
2007-09-05 |
Massachusetts Inst Technology |
ANTICANCER TREATMENT BASED ON DNA
|
US20060026699A1
(en)
*
|
2004-06-04 |
2006-02-02 |
Largaespada David A |
Methods and compositions for identification of genomic sequences
|
JP4764426B2
(ja)
|
2004-06-07 |
2011-09-07 |
プロチバ バイオセラピューティクス インコーポレイティッド |
カチオン性脂質および使用方法
|
EP1766035B1
(en)
|
2004-06-07 |
2011-12-07 |
Protiva Biotherapeutics Inc. |
Lipid encapsulated interfering rna
|
US7807815B2
(en)
|
2004-07-02 |
2010-10-05 |
Protiva Biotherapeutics, Inc. |
Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
|
EP1948674A4
(en)
|
2005-11-02 |
2009-02-04 |
Protiva Biotherapeutics Inc |
MODIFIED SIRNA MOLECULES AND APPLICATIONS THEREOF
|
US7915399B2
(en)
|
2006-06-09 |
2011-03-29 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
US20080312174A1
(en)
*
|
2007-06-05 |
2008-12-18 |
Nitto Denko Corporation |
Water soluble crosslinked polymers
|
KR20100065190A
(ko)
*
|
2007-09-14 |
2010-06-15 |
닛토덴코 가부시키가이샤 |
약물 담체
|
EP2047858A1
(en)
|
2007-10-10 |
2009-04-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Combination products for treating cancer
|
DE102008016275A1
(de)
|
2008-03-28 |
2009-11-19 |
Biontex Laboratories Gmbh |
Verbesserung von Transfektionsergebnissen nicht-viraler Genliefersysteme durch Blockierung des angeborenen Immunsystems
|
WO2009065618A2
(de)
|
2007-11-22 |
2009-05-28 |
Biontex Laboratories Gmbh |
Verbesserung von transfektionsergebnissen nicht-viraler genliefersysteme durch beeinflussung des angeborenen immunsystems
|
DE102008023913A1
(de)
|
2008-05-16 |
2009-11-19 |
Biontex Laboratories Gmbh |
Verbesserung von Transfektionsergebnissen nicht-viraler Genliefersysteme durch Beeinflussung des angeborenen Immunsystems
|
DE102007056488A1
(de)
|
2007-11-22 |
2009-07-23 |
Biontex Laboratories Gmbh |
Steigerung von Transfektionseffizienzen nicht-viraler Genliefersysteme durch Blockierung des angeborenen Immunsystems
|
GB0724253D0
(en)
|
2007-12-12 |
2008-01-30 |
Fermentas Uab |
Transfection reagent
|
WO2009082817A1
(en)
|
2007-12-27 |
2009-07-09 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering rna
|
US7687027B2
(en)
*
|
2008-02-27 |
2010-03-30 |
Becton, Dickinson And Company |
Cleaning compositions, methods and materials for reducing nucleic acid contamination
|
FR2928373B1
(fr)
*
|
2008-03-05 |
2010-12-31 |
Centre Nat Rech Scient |
Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
|
JP2011516094A
(ja)
|
2008-04-15 |
2011-05-26 |
プロチバ バイオセラピューティクス インコーポレイティッド |
干渉rnaを用いたcsn5遺伝子発現のサイレンシング方法
|
NZ588583A
(en)
|
2008-04-15 |
2012-08-31 |
Protiva Biotherapeutics Inc |
Novel lipid formulations for nucleic acid delivery
|
US8637315B2
(en)
*
|
2008-05-15 |
2014-01-28 |
National Research Council Of Canada |
Process, vectors and engineered cell lines for enhanced large-scale transfection
|
CA2740000C
(en)
|
2008-10-09 |
2017-12-12 |
Tekmira Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
WO2010078194A1
(en)
*
|
2008-12-30 |
2010-07-08 |
Streck, Inc. |
Method for screening blood using a preservative that may be in a substantially solid state form
|
US11634747B2
(en)
*
|
2009-01-21 |
2023-04-25 |
Streck Llc |
Preservation of fetal nucleic acids in maternal plasma
|
DE102009006606A1
(de)
|
2009-01-29 |
2010-08-05 |
Philipps-Universität Marburg |
Nicht-virales Transfektionsmittel
|
EP3778919A1
(en)
|
2009-02-18 |
2021-02-17 |
Streck Inc. |
Preservation of cell-free nucleic acids
|
WO2010125544A1
(en)
|
2009-04-30 |
2010-11-04 |
Genetic Immunity Kft. |
Immunogenic nanomedicine composition and preparation and uses thereof
|
JP5766188B2
(ja)
|
2009-07-01 |
2015-08-19 |
プロチバ バイオセラピューティクス インコーポレイティッド |
固形腫瘍に治療剤を送達するための脂質製剤
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
EP2488210A4
(en)
|
2009-10-12 |
2014-04-30 |
Smith Holdings Llc |
METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING IN VITO OR IN VITRO-ADMINISTERED OLIGONUCLEOTIDE MEDICAMENTS
|
US9856456B2
(en)
*
|
2009-10-12 |
2018-01-02 |
Thermo Fisher Scientific Baltics Uab |
Delivery agent
|
GB0917792D0
(en)
*
|
2009-10-12 |
2009-11-25 |
Fermentas Uab |
Delivery agent
|
CA2780536C
(en)
|
2009-11-09 |
2018-01-02 |
Streck, Inc. |
Stabilization of rna in and extracting from intact cells within a blood sample
|
WO2011117352A1
(en)
|
2010-03-24 |
2011-09-29 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Primate model from the family cercopithecidae infected by a hbv strain of human genotype
|
US8945927B2
(en)
|
2010-03-29 |
2015-02-03 |
Universite De Strasbourg |
Polymers for delivering molecules of interest
|
CA2802994A1
(en)
|
2010-06-17 |
2011-12-22 |
The United States Of America As Represented By The Secretary, National I Nstitutes Of Health |
Compositions and methods for treating inflammatory conditions
|
RS57439B1
(sr)
|
2010-06-22 |
2018-09-28 |
Onxeo |
Optimizovani sistem sa endosomolitičkim agensima za in vivo primenu konjugata nukleinskih kiselina
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
EP2704740B1
(en)
|
2011-05-04 |
2016-10-05 |
Streck, Inc. |
Inactivated swine flu virus and methods of preparing it
|
US20140234373A1
(en)
|
2011-09-16 |
2014-08-21 |
Georfia Regents University |
Methods of Promoting Immune Tolerance
|
JP2014533953A
(ja)
|
2011-11-17 |
2014-12-18 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
治療用rnaスイッチ組成物及び使用方法
|
WO2013076309A1
(en)
|
2011-11-24 |
2013-05-30 |
Genethon |
Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
DK2858677T3
(da)
*
|
2012-06-08 |
2020-08-31 |
Ethris Gmbh |
Pulmonær levering af messenger rna
|
CN103059295B
(zh)
*
|
2012-09-26 |
2016-01-13 |
上海交通大学 |
疏水修饰的聚乙烯亚胺及其作为蛋白质载体的用途
|
EP4085930A1
(en)
|
2012-10-05 |
2022-11-09 |
BioNTech Delivery Technologies GmbH |
Hydroxylated polyamine derivatives as transfection reagents for rna
|
CN104703629B
(zh)
|
2012-10-08 |
2020-12-01 |
生物技术传送科技有限责任公司 |
作为转染试剂的羧化多胺衍生物
|
DE102012111891A1
(de)
*
|
2012-12-06 |
2014-06-12 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Verbesserung der Zielfindungskapazität von Stammzellen
|
ES2938048T3
(es)
|
2013-07-24 |
2023-04-04 |
Streck Llc |
Composiciones y procedimientos para estabilizar las células tumorales circulantes
|
EP3068891A1
(en)
|
2013-11-13 |
2016-09-21 |
Aequus Biopharma Inc. |
Engineered glycoproteins and uses thereof
|
EP3201338B1
(en)
|
2014-10-02 |
2021-11-03 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis b virus gene expression
|
EP3034539A1
(en)
*
|
2014-12-19 |
2016-06-22 |
Ethris GmbH |
Compositions for introducing nucleic acid into cells
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
CA2984879A1
(en)
|
2015-05-05 |
2016-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Nucleic acid-cationic polymer compositions and methods of making and using the same
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
US20180208932A1
(en)
|
2015-07-29 |
2018-07-26 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis b virus gene expression
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
US10010627B2
(en)
|
2016-06-03 |
2018-07-03 |
International Business Machines Corporation |
Modified polycationic polymers
|
US11506655B2
(en)
|
2016-07-29 |
2022-11-22 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
CN110418650A
(zh)
|
2016-11-16 |
2019-11-05 |
免疫治疗有限公司 |
用于治疗过敏的核酸
|
EP3570814B1
(en)
|
2017-01-19 |
2023-11-29 |
Universiteit Gent |
Molecular adjuvants for enhanced cytosolic delivery of active agents
|
US11203629B2
(en)
|
2017-04-22 |
2021-12-21 |
Immunomic Therapeutics, Inc. |
LAMP constructs
|
BR112019023014A2
(pt)
|
2017-05-02 |
2020-05-19 |
Immunomic Therapeutics Inc |
constructos de lamp aperfeiçoados compreendendo antígenos de câncer
|
US20210261647A1
(en)
|
2018-05-15 |
2021-08-26 |
Immunomic Therapeutics, Inc |
Lamp constructs comprising allergens
|
MX2021008392A
(es)
|
2019-01-10 |
2021-10-26 |
Janssen Biotech Inc |
Neoantígenos prostaticos y sus usos.
|
KR20220083773A
(ko)
|
2019-10-18 |
2022-06-20 |
이뮤노믹 쎄라퓨틱스, 인크. |
암 항원을 포함하는 개선된 lamp 구축물
|
PE20221182A1
(es)
|
2019-11-18 |
2022-08-05 |
Janssen Biotech Inc |
Vacunas basadas en calr y jak2 mutantes y sus usos
|
WO2022009052A2
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
EP4176087A1
(en)
|
2020-07-06 |
2023-05-10 |
Janssen Biotech, Inc. |
A method for determining responsiveness to prostate cancer treatment
|
US20230024133A1
(en)
|
2020-07-06 |
2023-01-26 |
Janssen Biotech, Inc. |
Prostate Neoantigens And Their Uses
|
CN112237633B
(zh)
*
|
2020-10-22 |
2023-06-27 |
林君玉 |
一种pei/on复合物及其制备方法和用途
|
WO2022115645A1
(en)
|
2020-11-25 |
2022-06-02 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids, and related methods of use
|
GB202108176D0
(en)
|
2021-06-08 |
2021-07-21 |
Touchlight Ip Ltd |
Vector
|
WO2022258967A1
(en)
|
2021-06-08 |
2022-12-15 |
Touchlight IP Limited |
Lentiviral vector
|
WO2023201201A1
(en)
|
2022-04-10 |
2023-10-19 |
Immunomic Therapeutics, Inc. |
Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof
|
WO2023230587A2
(en)
|
2022-05-25 |
2023-11-30 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
|